medulloblastoma

Showing 1 - 25 of 78

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children,

Not yet recruiting
  • Anaplastic Astrocytoma
  • +17 more
    • (no location specified)
    Jun 28, 2023

    CNS Tumors, Atypical Teratoid/Rhabdoid Tumor, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Memphis (B7-H3-CAR T cells)

    Not yet recruiting
    • Central Nervous System Neoplasms
    • +6 more
    • B7-H3-CAR T cells
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Apr 18, 2023

    Medulloblastoma Trial (drug, other, radiation)

    Recruiting
    • Medulloblastoma
    • Madera, California
    • +1 more
    Jan 30, 2023

    Radiation Therapy in Pediatric Central Nervous System Tumors

    Completed
    • Diffuse Intrinsic Pontine Glioma
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 26, 2023

      CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (EGFR806-specific chimeric antigen receptor (CAR) T cell)

      Active, not recruiting
      • Central Nervous System Tumor, Pediatric
      • +8 more
      • EGFR806-specific chimeric antigen receptor (CAR) T cell
      • Seattle, Washington
        Seattle Children's Hospital
      Jan 18, 2023

      High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))

      Recruiting
      • High Grade Glioma
      • +12 more
      • LUTATHERA® (Lutetium Lu 177 dotatate)
      • Aurora, Colorado
      • +8 more
      Jan 16, 2023

      Medulloblastoma, CNS Tumor, Pediatric, Ependymoma Trial in Beijing

      Recruiting
      • Medulloblastoma
      • +5 more
        • Beijing, Beijing, China
          Beijing Tiantan Hosiptal
        Jan 3, 2023

        Neuroblastoma, Medulloblastoma Trial in United States (Nifurtimox, Cyclophosphamide, Topotecan)

        Completed
        • Neuroblastoma
        • Medulloblastoma
        • San Diego, California
        • +14 more
        Dec 28, 2022

        Medulloblastoma, Medulloblastoma, Childhood, Medulloblastoma Recurrent Trial in United States (Specialized Tumor Board Treatment

        Recruiting
        • Medulloblastoma
        • +2 more
        • Specialized Tumor Board Treatment Plan
        • San Diego, California
        • +3 more
        Dec 28, 2022

        Ependymoma, Medulloblastoma, Glioblastoma Trial in Augusta (Ibrutinib, Indoximod, Cyclophosphamide)

        Recruiting
        • Ependymoma
        • +3 more
        • Augusta, Georgia
          Augusta University, Georgia Cancer Center
        Dec 16, 2022

        CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (HER2-specific chimeric antigen receptor (CAR) T cell)

        Recruiting
        • Central Nervous System Tumor, Pediatric
        • +8 more
        • HER2-specific chimeric antigen receptor (CAR) T cell
        • Seattle, Washington
          Seattle Children's Hospital
        Dec 14, 2022

        Ependymoma, Ewing Sarcoma, High-grade Glioma Trial in Worldwide (Nivolumab, NKTR-214)

        Completed
        • Ependymoma
        • +9 more
        • Nivolumab
        • NKTR-214
        • Little Rock, Arkansas
        • +17 more
        Dec 8, 2022

        DOTATOC PET/CT for Imaging NET Patients

        Recruiting
        • Neuroendocrine Tumors
        • +15 more
        • 68Ga-DOTATOC PET/CT
        • 18F-FDG PET/CT
        • Vancouver, British Columbia, Canada
          BC Cancer
        Nov 2, 2022

        Brain Tumor, Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Memphis (Prexasertib, Cyclophosphamide, Gemcitabine)

        Active, not recruiting
        • Brain Tumor
        • +12 more
        • Memphis, Tennessee
          St. Jude Children's Research Hospital
        Oct 20, 2022

        Neuroendocrine Tumors, Meningioma, Neuroblastoma Trial in Iowa City (radiation, diagnostic test, drug)

        Active, not recruiting
        • Neuroendocrine Tumors
        • +3 more
        • 90Y-DOTA tyr3-Octreotide
        • +2 more
        • Iowa City, Iowa
          University of Iowa Hospitals and Clinics
        Oct 6, 2022

        CNS Tumors, Medulloblastoma Trial in Worldwide (Pomalidomide)

        Active, not recruiting
        • Central Nervous System Neoplasms
        • Medulloblastoma
        • Stanford, California
        • +24 more
        Sep 28, 2022

        68-Ga DOTATATE PET/MRI in Diagnosis and Management of

        Recruiting
        • CNS Tumors
        • +6 more
        • Ga68-DOTATATE-PET/MRI
        • New York, New York
          Weill Cornell Medicine
        Sep 20, 2022

        Medulloblastoma Trial in Memphis (procedure, drug, radiation)

        Recruiting
        • Medulloblastoma
        • Surgical resection
        • +11 more
        • Memphis, Tennessee
          St. Jude Children's Research Hospital
        Sep 16, 2022

        Ewing Sarcoma, Solid Tumors, Rhabdoid Tumor Trial in Worldwide (Palbociclib, Temozolomide, Irinotecan)

        Recruiting
        • Ewing Sarcoma
        • +6 more
        • Birmingham, Alabama
        • +83 more
        Aug 19, 2022

        Brain Tumor, Medulloblastoma Trial in Memphis ([18F]DPA714)

        Recruiting
        • Brain Tumor
        • Medulloblastoma
        • Memphis, Tennessee
          St.Jude Children's Research Hospital
        Aug 17, 2022

        Medulloblastoma Trial in Worldwide (drug, other, radiation)

        Recruiting
        • Medulloblastoma
        • Birmingham, Alabama
        • +192 more
        Aug 17, 2022

        Anaplastic Ependymoma, Atypical Teratoid/Rhabdoid Tumor, CNS Germ Cell Tumor Trial in Houston (drug, procedure, biological)

        Recruiting
        • Anaplastic Ependymoma
        • +14 more
        • Houston, Texas
          M D Anderson Cancer Center
        Aug 17, 2022

        Medulloblastoma Trial in United States (Difluoromethylornithine)

        Recruiting
        • Medulloblastoma
        • Little Rock, Arkansas
        • +12 more
        Aug 3, 2022